|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
ZS reports find that 53% of physician engagements aren't in person.  Read the ZS summary for more AffinityMonitor™ and AccessMonitor™ insights.
|
|
| Advertisement |
Technology can't replace people- why Patient Support Programs need a personal approach
Live Webcast: Thursday, September 29 at 8:00 EDT
 Free registration |
|
| Advertisement |
Optimizing real-world evidence programs to generate value
Tailored approaches for emerging biopharma
On Demand
 Learn more |
|
| Special Feature |
 |
|
Pharm Exec's Emerging Pharma Leaders 2016 |
Pharm Exec's 9th annual list of rising industry leaders illustrates how the deployment of essential human capital has changed in line with a business model that is no longer static and predictable—or complacent
... /Read more/ |
|
| Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
 Learn more |
|
|
ADVERTISEMENT
|
| Advertisement |
Best Practices for Integrating Biomarkers across the Drug Development Continuum
On Demand
 Learn more |
|
| Industry update |
| //Sanofi appointed Dr. Frank Nestle as both the global head of immunology and inflammation research therapeutic area and North America Chief Scientific Officer.//Dragonfly Therapeutics (Cambridge, MA) announced the addition Dr. Patrick Hwu, of the University of Texas MD Anderson Cancer Center, to its Scientific Advisory Board. //ClearLight Diagnostics (Sunnyvale, CA) announced the appointment of Laurie Goodman, Ph.D as Chief Scientific Officer.// |
|
|
| |
|
